News About: Pharm. Industry
Hanmi Pharm to launch first-ever testosterone replacement gel in next March
Hanmi Pharm said recently it would market a male hormone replacement therapy in March next year.
TestoGel, the first-ever testosterone replacement gel in men for conditions associated with low testosterone.
The ...
More than 800 drugs completed bio-equivalencies.
The KFDA announced that as of Nov. 11 the total 803 drugs passed through its bio-equivalency test, surpassing this year target of 800.
In 2002 the KFDA launched the 4 year implementation project for the bio equiva...
LG Life Sciences eyes M&A with GeneSoft within this year
LG Life Sciences might take its M&A bid to the US-based GeneSoft within this year to independently promote Factive in the global market due to the approval of additional indications, such as PRSP (Penicillin-resistant...
Proper drug margin is essential for pharmaceutical industry
In a brief session with IFPMA Chairman Dr. Harvey E. Bale Jr., who visited the Korea Pharmaceutical Manufacturers Association on November 13, the association's chairman Kim Chung-soo and president Rhee Jang-han (chair...
Tylenol receives 2003 Brand Award
Janssen Korea's Tylenol was selected as one of 2003 brands in the local pharmaceutical sector on November 14, according to the recent survey of 253,000 customers that was conducted by the Korea Consumer Forum and the ...
Korean crude drugs to attract world's interests.
A 3-day world exhibition event for the pharmaceutical raw materials took place at Frankfurt in Germany from Oct. 27 to 29 under the title of "CPhI Worldwide 2003" where 13 Korean participants in the exhibition booths ...
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be...
Pharmaceutical firms vigorously bracing for launching first generic versions of soon-to-be expired patent drugs
Many major pharmaceutical firms are scurrying to introduce the first generic versions of soon-to-be ex...
Dong-A Pharm Chairman accepts FKI's acting chiefKang Shin-ho, chairman of Dong-A Pharm, accepted an offer to serve as the acting chief of the Federation of Korean Industries during a meeting of its member companies' leaders o...
|
Wyeth Korea to launch pneumococcal conjugated vaccine PrevenarWyeth Korea announced on November 12 that Prevenar received marketing authorization from the Korea Food and Drug Administration.
The vaccine is the first and only pneumococc...
|
Green Cross Sang-A achieved 116% sales and 54% income.
Green Cross Sang-A has made a substantial jump in their sales and ordinary incomes during the 3rd quarter of this year according to the company official reports on Nov. 12.
The report describes that the company ach...
